Management Forum Logo

Presented by
Management Forum

Risk Management in Clinical Research and Trials Training Course

Now includes a forward-looking module on how AI is shaping the future of risk management in clinical trials

This essential course will explain the importance of using risk management techniques in clinical trials to comply with the latest focus on inspection in this area.

★★★★★ "Very good"

24 April 2026
+ 6 October 2026 »

from £649

Need help?  Enrol/reserve

Course overview

Effective risk management is now at the heart of running high‑quality, compliant clinical trials. With the shift toward proportionate, risk‑based approaches in ICH E6 (R3), E6 (R2), and ICH E8(R1), teams are expected not only to identify and evaluate risks early, but also to monitor and respond to them in a structured, transparent way throughout the trial lifecycle.

This interactive one‑day course gives you the confidence and skills to apply modern risk management principles in real studies. Through clear explanations, real‑world examples, and interactive discussions, we explore what regulators expect, how risk‑based quality management works in practice, and how to build a process that supports both participant safety and high‑quality data.

The course also introduces the growing role of AI in clinical trial risk management. You’ll learn how emerging tools can support early risk detection, help identify unusual data patterns, and strengthen centralised monitoring - while also understanding their limitations and the importance of maintaining strong documentation, oversight, and human judgement.

By the end of the day, you will be equipped to design, implement, and document a practical, proportionate risk management approach that aligns with the latest global expectations and supports successful clinical trial delivery.

Browse our extensive selection of Life Sciences training courses for industry-leading insights into a range of topics. These include Medical Devices, IVDs, Biotech and Biopharma, Animal Health and Pharmaceutical training courses.

Benefits of attending

  • Understand key risk management tools and when to apply them in pharma, biopharma, projects
  • Learn how to plan, document, and focus risk-based approaches to meet ICH GCP E6 (R2), E6 (R3), and related regulatory expectations
  • Identify and share best practices for implementing risk-based tools and approaches in clinical trials including AI
  • Gain a clear understanding of the risk management objectives outlined in ICH E6 (R3) and ICH E8(R1)

Who should attend

This course is designed for professionals in the pharmaceutical, biotechnology industry who need to understand and apply risk management in clinical research, including:

  • Clinical Research Associates (CRAs)
  • Clinical Trial Managers (CTMs)
  • Quality Assurance professionals
  • Regulatory Affairs specialists
  • Project Managers
  • Data Managers
  • Anyone needing to meet regulatory expectations and apply risk-based tools and techniques effectively in their role

Enrol/reserve

This course will cover:

Regulatory frameworks and guidelines

  • Overview of regulations and guidance covering risk management in pharma and biopharma
  • ICH GCP E6 (R3) risk considerations, including:
    • Proportionate Risk-Based Approach
    • Critical to Quality (CtQ) Factors Identification
    • Defining and applying Quality Tolerance Limits (QTLs)
    • Risk Assessment & Management
    • Sponsor and Investigator Responsibilities
    • How ICH E8(R1) complements E6 (R3) in setting quality expectations

Risk-based quality management systems (QMS)

  • What a risk-based QMS means in practice for clinical research
  • Core QMS elements that incorporate risk
  • What regulatory inspectors expect to see in place for clinical trials

Risk-based processes, tools, and techniques

  • Examples of effective risk management processes in clinical research
  • Practical tools for risk identification, assessment, and control, including:
    • Root Cause Analysis
    • Risk Breakdown Structure
    • Risk Matrix
    • Risk Prioritisation (scoring systems, heat maps)
    • Risk Log/register and Tracking
    • Failure Mode and Effect Analysis (FMEA)

Clinical trial-specific risk tools

  • Pharmaceutical risk-specific tools, including the Risk Assessment Categorisation Tool and how this is being replaced

Enrol/reserve

Laura Brown
Independent Pharmaceutical Consultant

Dr Laura Brown is an independent pharmaceutical QA, management and training consultant and Senior Lecturer for the MSc in Clinical Research, School of Pharmacy, University of Cardiff. Laura has more than 20 years’ experience of quality assurance and managing international clinical trials including risk identification and management. She has worked for several leading companies including GSK, Hoechst Marion Roussel, Good Clinical Research Practices and Phoenix International and is an international expert on GCP and clinical trial requirements. Laura was chair of the Institute of Clinical Research GCP Forum for six years and writes regularly on clinical research regulatory requirements.

More details

NEW higher discounts for multiple bookings - bring your colleagues to make your training budget go further:

  • 30% off the 2nd delegate*
  • 40% off the 3rd delegate*
  • 50% off the 4th delegate*

Please contact us for pricing if you are interested in booking 5 or more delegates

24 April 2026

Live online

09:30-17:00 UK (London) (UTC+01)
10:30-18:00 Paris (UTC+02)
04:30-12:00 New York (UTC-04)
Course code 16872

  • GBP 649 749
  • EUR 909 1,049
  • USD 1,043 1,199

Until 20 Mar

View basket 

 
Not ready to book yet?

for 7 days, no obligation

6 October 2026

Live online

09:30-17:00 UK (London) (UTC+01)
10:30-18:00 Paris (UTC+02)
04:30-12:00 New York (UTC-04)
Course code 16873

  • GBP 649 749
  • EUR 909 1,049
  • USD 1,043 1,199

Until 01 Sep

View basket 

 
Not ready to book yet?

for 7 days, no obligation

* Early booking discounts may not be combined with other discounts or offers. As such, the discounts for 2nd/3rd/4th delegates are based on the full price; and apply only when booking multiple delegates on the same date.

Reviews of IPI's Risk Management in Clinical Research and Trials training course


There were lots of useful links and information which I can use for further study of the risk management concepts and their application.

Oct 8 2024

Vladilena Daly
Operations and Compliance Manager, CliebntPharma Ltd

Oct 14 2022

Very good

Arna Hrund Arnardottir
Senior Consultant RA, DADA Consultancy BV

United Kingdom

  • Grifols UK Ltd
  • St George's University Hospital
  • Veeva

Belgium

  • Nikkiso Belgium

Finland

  • Oy Medfiles Ltd

France

  • IPSEN

Germany

  • Boehringer Ingelheim Pharma GmbH & Co KG

Ireland

  • CliebntPharma Ltd

Netherlands

  • DADA Consultancy BV

Portugal

  • NOVA Medical School

Enrol/reserve

Run Risk Management in Clinical Research and Trials Live online for your team

1 day

Typical duration

Pricing from:

  • GBP 500
  • Per attendee, based on 10 attendees
  • Course tailored to your requirements
  • At your choice of location, or online

 

We can customise this course to your requirements and deliver it on an in-house basis for any number of your staff or colleagues.

Contact our in-house training experts Aleksandra Beer and Yesim Nurko to discuss your requirements:

Multiple colleagues? See above for details of our discounts for 2, 3, or 4 delegates. For more, talk to one of our training experts to discuss how to:

Run this course conveniently and cost-effectively in-house for your staff and colleagues

Aleksandra Beer

Aleksandra
BEER

Training expert

Yesim Nurko

Yesim
NURKO

Training expert

Yesim Nurko

Harry
ALTAMONT

Training expert

+44 (0)20 7749 4749

inhouse@ipiacademy.com